Шығарылым |
Атауы |
Файл |
№ 3 (2023) |
Thin endometrium as one of the causes of IVF failures |
|
Aryutin D.
|
№ 10 (2023) |
BRCA-associated breast cancer during pregnancy |
|
Bakhova L., Shevlyukova T., Keln A., Shvedsky M., Mateykovich E., Nekrasova O., Shkuratova V., Karmaeva O.
|
№ 3 (2023) |
HELLP syndrome in a pregnant woman with a salt-wasting form of congenital adrenal hyperplasia |
|
Kirsanova T., Sazonova A., Klimenchenko N., Esayan R., Gerasimov Y., Sakhnova E.
|
№ 6 (2024) |
Activation of ovarian function in patients with diminished ovarian reserve through administration of extracellular vesicles |
|
Martirosyan Y., Nazarenko T., Kadaeva A., Goryunov K., Shevtsova Y.
|
№ 3 (2023) |
Activated glycyrrhizic acid in the combination treatment of patients with vaginitis and dysbiosis: results of a multicenter study |
|
Kachalina O., Matuzkova A.
|
№ 2 (2023) |
Obstetric and neonatal outcomes of different management strategies in fetal macrosomia |
|
Tysyachnyi O., Baev O., Chausov A., Edilberg I., Gaidarova A.
|
№ 3 (2024) |
Algorithm for diagnosis and treatment of gastroesophageal reflux disease in pregnant women |
|
Tyutyunnik V., Kan N., Mikhailova O., Mirzabekova D.
|
№ 6 (2024) |
Analysis of pathomorphological characteristics of the placental structure in cases of prenatally diagnosed fetal congenital heart disease |
|
Yarygina T., Gasanova R., Marzoeva O., Sypchenko E., Leonova E., Lyapin V., Shchegolev A., Gus A.
|
№ 3 (2023) |
Analysis of HLA class I gene (G) polymorphic alleles in pregnant women in the North-West Region of the Russian Federation |
|
Shengelia M., Bespalova O., Ivashchenko T., Frank N., Sultanov I., Nasykhova Y., Glotov A.
|
№ 5 (2024) |
Analysis of the structure of gynecological diseases and extent of surgery in patients of different age groups supervised in the cervical and endometrial pathology office |
|
Rosyuk E., Oboskalova T., Verba T., Salimova I., Tureeva A.
|
№ 3 (2024) |
Analogues of gonadotropin-releasing hormone in the treatment of women with uterine fibroids |
|
Dovletkhanova E., Abakarova P., Mezhevitinova E.
|
№ 2 (2023) |
Antibodies to angiotensin-converting enzyme 2 in infertile patients with a history of COVID-19 and in fertile women |
|
Menzhinskaya I., Ermakova D., Syrkasheva A., Drapkina Y., Dolgushina N.
|
№ 5 (2024) |
Association of COL1A1, ESR1, and VDR gene polymorphisms with the risk of pelvic floor dysfunction in postpartum women |
|
Mikhelson A., Lukianova K., Lazukina M., Varlamova A., Tretyakova T., Varaksin A., Konstantinova E., Maslakova T.
|
№ 3 (2024) |
COVID-19-associated placental damage |
|
Pilkevich N., Markovskaya V., Khabibullin R., Yavorskaya O., Smirnova A.
|
№ 3 (2024) |
Balance of pro-inflammatory and anti-inflammatory cytokines of fetal membranes of patients with prelabor rupture of membranes at term |
|
Kaganova M., Spiridonova N.
|
№ 6 (2024) |
Balance of serum cytokines regulating inflammatory activity in patients with leiomyoma |
|
Konenkov V., Shevchenko A., Koroleva E., Prokofiev V., Timofeeva Y., Aidagulova S., Marinkin I.
|
№ 3 (2023) |
Transversus abdominis plane nerve blocks in the concept of enhanced recovery after a cesarean section |
|
Kornienko A., Nitchenko A., Troshin P., Pyregov A.
|
№ 2 (2023) |
Rapid urine test for bacteriuria and beta-lactam resistance in uropathogenic enterobacteria |
|
Shipitsyna E., Khusnutdinova T., Goloveshkina E., Gromova A., Skachkova T., Krysanova A., Savicheva A.
|
№ 3 (2024) |
Vasoactive endothelial factors in women with poor and suboptimal ovarian response during infertility treatment using assisted reproductive technologies |
|
Perfilova V., Muzyko E., Tikhaeva K., Kustova M., Mukhina A., Fokina A., Zhuravleva E.
|
№ 5 (2024) |
The variability in the clinical effects of indolcarbinol in women with mastodynia |
|
Vorontsova A., Zvychayny M., Guzhavina P.
|
№ 2 (2023) |
Association between new coronavirus infection and fetal growth restriction |
|
Lipatov I., Tezikov Y., Kalinkina O., Tyutyunnik V., Kan N., Majorova M., Yakovleva M.
|
№ 4 (2023) |
Impact of hormone therapy on the overall and relapse-free survival of patients receiving treatment for ovarian cancer |
|
Babaeva N., Yureneva S., Aleshikova O., Yakushevskaya O., Ashrafyan L.
|
№ 5 (2024) |
The influence of dysbiotic disorders and local inflammatory reactions in the reproductive tract on the development of preterm birth |
|
Medzhidova M., Tyutyunnik V., Kan N., Donnikov A., Mikhailova O.
|
№ 6 (2024) |
The effect of nursing mothers’ diet on breast milk composition |
|
Egorova A., Puzankina P., Babaeva S., Timofeev M., Molkova A.
|
№ 6 (2024) |
Effect of preconceptional cervical electroconizationon the course of pregnancy and childbirth |
|
Rosyuk E., Oboskalova T., Emelyanova E., Butorina N., Emelyanova T., Glukhov E., Neff E., Yakushev A.
|
№ 3 (2023) |
Intra-abdominal hemorrhage in a pregnant woman as a manifestation of endometrioid disease |
|
Tezikov Y., Lipatov I., Tezikova T., Kalinkina O., Zumorina E., Amosov M., Tyutyunnik V., Kan N.
|
№ 6 (2024) |
Intrauterine correction of open forms of spina bifida: comparative analysis of the results of V.I. Kulakov NMRC for OG&P of Minzdrav of Russia and the MOMS multicenter randomized trial |
|
Petrova U., Shmakov R., Zinenko D., Gladkova K., Kostyukov K., Nikolaeva A., Sakalo V., Ostrik K., Chugunova L., Shramko A., Tarasenko Y., Berdichevskaya E., Balashova E., Ionov O.
|
№ 5 (2024) |
Possibilities of antibacterial therapy in patients with mixed infections of the vagina and cervix: the results of the Flora Centrum study |
|
Apolikhina I., Boris D., Iurova M., Gorbunova E., Teterina T.
|
№ 6 (2024) |
Possibilities of the biologically active complex of phytopreparations in the correction of menopausal disorders |
|
Yashchuk A., Dautova L., Shaikhutdinova O., Muslimova L., Berg P., Berg E., Nasyrova S., Kizko I., Nazyrova A.
|
№ 2 (2023) |
Potentials of the current pharmacotherapy of endometriosis |
|
Dumanovskaya M., Tabeeva G., Ivannikova J., Solopova A., Asaturova A., Smetnik A., Alieva P., Ermakova E., Pavlovich S.
|
№ 5 (2024) |
Tissue-selective estrogen regulation capabilities in postmenopausal women |
|
Yarmolinskaya M., Koloshkina A.
|
№ 2 (2023) |
Feasibility of predicting fetal growth restriction, by identifying plasma biomarkers |
|
Izhoykina E., Trifonova E., Kutsenko I., Stepanov I., Gavrilenko M., Stepanov V.
|
№ 10 (2023) |
Issues of ectogenesis and creation of the extracorporeal system for fetal development |
|
Yavorovskaya K., Goryachev A.
|
№ 4 (2023) |
Genetic determinants of adenomyosis |
|
Malysheva O., Yarmolinskaya M.
|
№ 3 (2023) |
Endometrial hyperplasia in women with comorbid obesity working in contact with organic solvents |
|
Marinkin I., Shpagina L., Lisova E., Kotova O., Kuznetsova G., Loktin E., Karmanovskaya S.
|
№ 4 (2023) |
Hysteroscopy for infertile women: experience of using anti-adhesion barriers |
|
Kozachenko I., Adamyan L.
|
№ 5 (2024) |
Smooth muscle tumors of the uterus: possibilities of preoperative diagnosis using imaging techniques |
|
Ivanova L., Chekalova M., Davydova I., Valiev R., Saryev M., Kryazheva V., Olimov B.
|
№ 3 (2023) |
Iron deficiency during pregnancy: effectiveness of therapy and key points for clinical practice |
|
Dzhobava E., Knysheva I., Artizanova D.
|
№ 10 (2023) |
Controversial issues of antenatal glucocorticoid use in fetal growth retardation |
|
Leonova A., Kan N., Tyutyunnik V., Borisova A., Gasymova S.
|
№ 4 (2023) |
Diffuse ectopic peritoneal deciduosis |
|
Misnik V., Oleneva M., Raksha A., Chernotalova N., Semenov Z., Ilyichev A., Lebedev I.
|
№ 3 (2024) |
Fetal growth retardation as a predictor of health during the future life |
|
Gumeniuk E., Ivshin A., Svetova K.
|
№ 3 (2023) |
The significance of three-dimensional ultrasound in the assessment of the state of the endometrium in patients with diffuse and nodular forms of adenomyosis |
|
Solomatina A., Ismaiilova P., Breusenko L., Shtyrov S., Tyumentseva M., Regul S., Khalifaeva Z.
|
№ 4 (2023) |
Excess adipose tissue and chronic subclinical inflammation in patients with polycystic ovary syndrome |
|
Kirillova E., Krechetova L., Vtorushina V., Ivanets T., Chernukha G.
|
№ 3 (2024) |
The changes in the landscape of the vaginal microbiome in patients undergoing complex treatment for mixed recurrent vaginal infections |
|
Kutsenko I., Borovikov I., Kravtsova E., Avakimyan A., Borovikova O., Andreeva A.
|
№ 6 (2024) |
Changes in the composition of intestinal microbiota and their association with cortisol, melatonin, tumor necrosis factor-α, and interleukin-17 levels in women with idiopathic recurrent miscarriage |
|
Gumenyuk L., Gavrilov M., Puchkina G., Asanova F., Medzhitova D., Bordyugov M., Tishchenko V., Rudeva K.
|
№ 3 (2024) |
Application of various machine learning techniques to the analysis of clinical, anamnestic, and embryological data of patients undergoing assisted reproductive technologies |
|
Drapkina Y., Makarova N., Vasiliev R., Amelin V., Frankevich V., Kalinina E.
|
№ 3 (2024) |
Association of polymorphic variants RS699517 and RS2790 of the maternal TYMS gene with newborn birthweight |
|
Reshetnikova Y., Ponomarenko I., Churnosov M., Reshetnikov E.
|
№ 3 (2024) |
Clinical and immunological characteristics of women in labor with COVID-19 and their newborn babies |
|
Inviyaeva E., Tysyachnyi O., Kosolapova Y., Vtorushina V., Baev O., Zubkov V., Krechetova L.
|
№ 4 (2023) |
Clinical and molecular aspects of autologous embryo-cumulus cells co-culture in ifv programs |
|
Asfarova G., Smolnikova V., Makarova N., Bobrov M., Eldarov C., Zingerenko B., Kalinina E.
|
№ 2 (2023) |
Fetal sacrococcygeal teratoma: new about an old problem |
|
Kadyrberdieva F., Syrkashev E., Kostyukov K., Shmakov R.
|
№ 4 (2023) |
Latent iron deficiency and iron-deficiency anemia in women with heavy menstruations |
|
Sokolova T., Marinkin I., Makarov K., Kuleshov V.
|
№ 2 (2023) |
Treatment for diffuse benign breast diseases |
|
Kravchenko E., Naboka M.
|
№ 3 (2024) |
Treatment for cyclic mastodynia in patients with benign breast diseases |
|
Kravchenko E., Naboka M., Sosnin M., Tsygankova M.
|
№ 3 (2023) |
Medical and social factors of infertility in Russia |
|
Korneeva I., Nazarenko T., Perminova S., Mityurina E., Cybizova T., Dashieva A.
|
№ 10 (2023) |
Interdisciplinary consensus on the use of high-intensity pulsed electromagnetic field therapy in the treatment of neurogenic pelvic pain |
|
Fomenko O., Shelygin Y., Apolikhina I., Bashankaev B., Martynov M., Morozov D., Shkoda A., Poryadin G., Suponeva N., Bakulin I., Pojdasheva A., Nikityuk D., Morozov S., Borodulina I., Teterina T., Danilov A., Dreval O., Chagava D., Salmasi Z., Korshunova E., Katunina E., Kasyan G., Gvozdev M., Isagulyan E., Kulikov A., Romanov D., Reutova A., Rumiantsev A., Popov A., Puchkov K., Fedorov A., Komantsev V., Ekusheva E., Vojtenkov V., Nikolaev S., Groshilin V., Genov P., Romikh V., Zakharchenko A., Shornikov P., Sinkin M., Dilanyan O., Ivozchikov S., Markaryan D., Danilov M., Shchyogolev A., Malinina O., Marchenko V., Silant'eva E., Kanaev S., Troshina E., Davletshina V., Pimenova E., Kashnikov V., Titov A., Aleshin D., Belousova S., Nekrasov M., Maslyukova A., Cherepakhina N., Ipatova M., Achkasov S.
|
№ 4 (2023) |
Impact of menopausal hormone therapy on immune system parameters |
|
Averyanova M., Yureneva S., Kiseleva V., Yakushevskaya O., Iskusnykh M., Elchaninov A., Fatkhudinov T., Vishnyakova P.
|
№ 3 (2024) |
Uterine fibroids: does the current paradigm of treatment require modernization? |
|
Levakov S., Kaviladze M., Guseynova S.
|
№ 5 (2024) |
Damage-associated molecular patterns in patients with intramural uterine fibroids and infertility |
|
Dubinskaya E., Kolesnikova S., Gasparov A., Alyoshkina E.
|
№ 5 (2024) |
Morphological characteristics of the endometrium in the preconception period, chorion and placenta during pregnancy resulting from in vitro fertilization in patients with chronic endometritis (secondary analysis of the results of the TULIP-2 randomized controlled trial) |
|
Sukhanov A., Dikke G., Kukarskaya I., Pesotskaya A.
|
№ 5 (2024) |
Early endometrial cancer in patients with congenital malformation of the genital organs |
|
Dvoynishnikova A., Shebzukhova Z., Pronin S., Khabas G.
|
№ 5 (2024) |
Undifferentiated connective tissue dysplasia in women of reproductive age: cross sectional study |
|
Grudnitskaya E., Nebyshynets L.
|
№ 6 (2024) |
Missed opportunities for improving the effectiveness of in vitro fertilization programs in patients with diminished ovarian reserve |
|
Krylova E., Pogosyan M.
|
№ 2 (2023) |
Non-developing pregnancy in the uterine scar after caesarean section: diagnostic difficulties |
|
Kurtser M., Breslav I., Kolotilova M., Barykina O., Scriabin N., Kurbatskaya O.
|
№ 5 (2024) |
Osteogenesis imperfecta and pregnancy |
|
Sviridova N., Tkachenko L., Verovskaya T., Skladanovskaya T., Shumakova N., Grammatikova O., Ryabchenko G., Shklyar A.
|
№ 4 (2023) |
Novel coronavirus infection in the third trimester of pregnancy: perinatal and maternal outcomes |
|
Malgina G., Dyakova M., Bychkova S., Grishkina A., Melkozerova O., Bashmakova N., Pepelyaeva N., Olkov S.
|
№ 10 (2023) |
Novel coronavirus infection and pregnancy: experience of three years of the pandemic |
|
Dyakova M., Bychkova S., Malgina G., Grishkina A., Chistiakova G.
|
№ 6 (2024) |
New possibilities for assessing the magnetic resonance characteristics of endometrioid ovarian cysts and their response to dienogest therapy |
|
Chernukha G., Solopova A., Pronina V.
|
№ 3 (2023) |
New advances in understanding the molecular mechanisms of human embryo implantation in in vitro fertilization programs |
|
Charaeva A., Makarova N., Drapkina Y., Kalinina E.
|
№ 10 (2023) |
Optimization of insulin therapy in a pregnant woman with concomitant type 1 diabetes mellitus and a single kidney |
|
Khasanova V., Yerbaktanova T., Yakubova E., Shevlyukova T., Arabaji O., Shvedsky M.
|
№ 4 (2023) |
Principles of early diagnosis of endometriosis based on the assessment of comorbidity and clinical manifestations |
|
Pronina V., Dumanovskaya M., Chernukha G.
|
№ 6 (2024) |
Clinical case of hemorrhagic stroke in a pregnant woman |
|
Ziganshin A., Tagirov M., Dikke G.
|
№ 4 (2023) |
Conservative treatment of atypical hyperplasia and endometrial carcinoma: immunohistochemical aspects |
|
Pashov A., Sivova E., Volkova L., Rachkovskaya V.
|
№ 3 (2024) |
Experience of treating patients with abnormal uterine bleeding associated with ovulatory dysfunction |
|
Dikke G., Novichkov D., Zulkarneeva E., Amirova K., Beraya A., Gartleb O., Cherezova Y., Akhmetgaliev A.
|
№ 10 (2023) |
Experience of using vaginal autoprobiotics in a patient with spontaneous triplet pregnancy with recurrent vaginal anaerobic dysbiosis |
|
Barinova V., Bushtyreva I., Kuznetsova N., Suvorov A., Botasheva T.
|
№ 6 (2024) |
Experience of using a combined melatonin-containing drug in the correction of sleep disorders in women |
|
Stenyaeva N., Khritinin D., Stenyaev E.
|
№ 5 (2024) |
Experience of laparoscopic transabdominal cerclage for correcting cervical incompetence |
|
Ldynina T., Pogodin O., Ivshin A., Shakurova E.
|
№ 3 (2024) |
Placenta Accreta Spectrum: experience of the surgical treatment |
|
Rymashevsky A., Volkov A., Kantsurova M.
|
№ 3 (2023) |
Pregnancy and delivery complications in endometriosis |
|
Shchegolev M., Tumanova U., Shchegolev A., Khilkevich E.
|
№ 3 (2024) |
Pain syndrome features in different forms of external genital endometriosis: a cross-sectional study |
|
Pronina V., Chernukha G., Filatova E., Solopova A.
|
№ 3 (2024) |
Gene expression features in patients with genital prolapse |
|
Cheremin M., Smolnova T., Krasnyi A., Chuprynin V.
|
№ 3 (2023) |
FMR1 inherited from women with premature ovarian failure: case series |
|
Rshtuni S., Zaretskaya N., Kuznetsova M., Marchenko L.
|
№ 3 (2023) |
The content of different forms of E-cadherin in blood plasma and placental tissue in preeclampsia |
|
Shelekhin A., Baev O., Sadekova A., Kokoeva D., Krasnyi A.
|
№ 2 (2023) |
The characteristics of pharmacokinetics and the biological effects of gonadotropin-releasing hormone agonists |
|
Rukhliada N., Birukova E.
|
№ 2 (2023) |
Acute twin-to-twin transfusion in monochorionic multiple pregnancy |
|
Mikhailov A., Romanovsky A., Volchenkova V., Kuznetsov A., Kyanksep A., Saveleva A., Osipova A., Tcyganova M.
|
№ 2 (2023) |
Cardiometabolic risk factors in women undergoing the menopausal transition and the potential of drospirenone-containing contraceptive in the correction of the identified abnormalities |
|
Tolstov S., Salov I., Rebrov A.
|
№ 2 (2023) |
Assessment of quality of life, psycho-emotional state, eating behavior, obstetric and perinatal outcomes in pregnant women with early and late gestational diabetes mellitus |
|
Batrak N., Malyshkina A., Tkachenko A.
|
№ 6 (2024) |
Endothelial functional activity in women of reproductive age and menopausal women with metabolic syndrome |
|
Shevlyukova T., Bulatova I.
|
№ 5 (2024) |
Primary prevention of human papillomavirus in Russia: analysis of international experience and determination of the best strategy |
|
Gorbunova E., Apolikhina I., Golubenko A., Priputnevich T.
|
№ 4 (2023) |
Prospects of treating infertility in women over 40 using assisted reproductive technology with autologous oocytes |
|
Khachatryan L., Makarova N., Kalinin A., Smolnikova V.
|
№ 2 (2023) |
Search for prognostic markers of the course of endometriosis |
|
Levakov S., Pertseva Y., Obukhova E., Paukov S., Bondarenko N., Shakhparonov M., Antipova N.
|
№ 10 (2023) |
Potential of first trimester plasma lipidome in high-risk pregnancy groups |
|
Minaeva E., Starodubtseva N., Shmakov R., Chagovets V., Tokareva A., Novoselova A., Kukaev E., Frankevich V.
|
№ 2 (2023) |
The practice of prescribing antimicrobials to pregnant women with concomitant somatic diseases |
|
Korobkov N., Bakulina N., Repina M., Arnt O.
|
№ 4 (2023) |
Predictors of infertility |
|
Barinova E., Aryutin D.
|
№ 3 (2024) |
The use of botulinum neuropeptide in gynecology |
|
Sokolova A., Ushakova K., Apolikhina I.
|
№ 10 (2023) |
Prediction of pregnancy outcomes in patients with cervical insufficiency undergoing cervical cerclage |
|
Pesegova S., Timokhina E., Strizhakov A., Ignatko I., Belousova V., Anokhina V.
|
№ 5 (2024) |
Prediction of neonatal complications based on quantitative proteome analysisin blood of pregnant women with fetal growth restriction |
|
Volochaeva M., Tokareva A., Bugrova A., Brzhozovskiy A., Kukaev E., Tyutyunnik V., Kan N., Starodubtseva N.
|
№ 3 (2023) |
Genital prolapse: Experience in surgical treatment |
|
Miklin O., Dyshlovaya A., Rumyantseva Z., Gudz O., Yermachkova P., Kravchenko A., Sulima A., Reznichenko N., Anikin S.
|
№ 5 (2024) |
Difference between maternal risk factors for fetal growth restriction and small for gestational age |
|
Ziyadinov A., Novikova V., Radzinsky V.
|
№ 10 (2023) |
Development and validation of models to predict total and early-onset preeclampsia in the first trimester of pregnancy using machine learning algorithms |
|
Andreychenko A., Luchinin A., Ivshin A., Ermak A., Novitskiy R., Gusev A.
|
№ 3 (2024) |
Early diagnosis of abnormally deep invasion of the chorion as a predictor of invasive placentation |
|
Volkov A., Solonchenko A., Rymashevsky A., Voloshin V., Khloponina A., Kantsurova M.
|
Нәтижелер 146 - 1/100 |
1 2 > >> |